European Assets Trust PLC - EAT.L

EAT.L Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
EAT.L	1.5	1.1	2.5	0.5	-4.4	-0.5	-31.1	-23.1	-15.7	675.7
S&P 500	0.8	1.7	2.8	4.2	9.6	25.7	38.2	83.5	195.5	34418.4

Compare EAT.L with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	EAT.L
name	European Assets Trust PLC
price	83
changes percentage	1.467
change	1.2
day low	81.4
day high	83.2
year high	102.97
year low	79.122
market cap	298857270
price avg 50	81.8902
price avg 200	85.3385
exchange	LSE
volume	1383727
avg volume	977826
open	81.8
previous close	81.8
eps	0.07
pe	11.86
earnings announcement	2025-03-18T08:30:00.000+0000
shares outstanding	360069000
timestamp	2025-01-22 16:35:29

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 12.7%

Overall Quarterly Financial Health: 27.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	36589000	-172112000	121.26
gross profit	33728000	-175316000	119.24
gross profit ratio	0.92	1.02	-9.50
research and development expenses	0	41.2	-100.00
operating expenses	1029000	995000	3.42
interest income	321000	34000	844.12
interest expense	705000	257000	174.32
ebitda	36280000	-172850000	120.99
ebitdaratio	0.99	1.0	-1.27
operating income	36295000	-172850000	121.00
operating income ratio	0.99	1.0	-1.23
net income	34888000	-174051000	120.04
net income ratio	0.95	1.01	-5.71
eps	0.1	-0.48	120.19

Overall Score of Annual Income Statement

None

Detailed Analysis

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	22103000	8232000	168.50
gross profit	20797000	6906000	201.14
gross profit ratio	0.94	0.84	12.16
research and development expenses	0	0	NaN
operating expenses	-575000	1257494	-145.73
interest income	0	240759	-100.00
interest expense	0	0	NaN
ebitda	20222000	6370000	217.46
ebitdaratio	0.91	0.77	18.23
operating income	20222000	6370000	217.46
operating income ratio	0.91	0.77	18.23
net income	19248000	5516000	248.95
net income ratio	0.87	0.67	29.96
eps	0.05	0.02	249.67

Overall Score of Quarterly Income Statement

0.43 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 22 million in 2024Q2 from 8 million in 2023Q4 representing a change of 168.5%. This indicates a sales shrinking, which is a negative sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 20 million in 2024Q2 from 6 million in 2023Q4 representing a change of 217.46%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 20 million in 2024Q2 from 6 million in 2023Q4 representing a change of 217.46%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 19 million in 2024Q2 from 6 million in 2023Q4 representing a change of 248.95%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 21 million in 2024Q2 from 7 million in 2023Q4 representing a change of 201.14%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to -1 million in 2024Q2 from 1 million in 2023Q4 representing a change of -145.73%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Earnings per Share (EPS): EPS increased to 0.05 in 2024Q2 from 0.05 in 2023Q4 representing a change of 249.67%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	380218000	357281000	6.42
total liabilities	26222000	9654000	171.62
total equity	353996000	347627000	1.83
cash and cash equivalents	2089000	13317000	-84.31
short term investments	0	0	NaN
long term investments	375066000	340717000	10.08
total current assets	2089000	16564000	-87.39
total non current assets	375066000	340717000	10.08
total current liabilities	0	7000	-100.00
total non current liabilities	0	7000	-100.00
common stock	37506000	37506000	0.00
retained earnings	0	345028870	-100.00
total debt	25996000	8872000	193.01

Overall Score of Annual Balance Sheet

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 380 million in 2023 from 357 million in 2022 representing a change of 6.42%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 354 million in 2023 from 348 million in 2022 representing a change of 1.83%. This indicates an increase in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities decreased to 0 million in 2023 from 0 million in 2022 representing a change of -100.0%. This indicates a lower short-term debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 26 million in 2023 from 10 million in 2022 representing a change of 171.62%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 2 million in 2023 from 13 million in 2022 representing a change of -84.31%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 2 million in 2023 from 17 million in 2022 representing a change of -87.39%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to 0 million in 2023 from 345 million in 2022 representing a change of -100.0%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 26 million in 2023 from 9 million in 2022 representing a change of 193.01%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	384422000	380218000	1.11
total liabilities	29908000	26222000	14.06
total equity	354514000	353996000	0.15
cash and cash equivalents	8538000	2089000	308.71
short term investments	0	0	NaN
long term investments	0	375066000	-100.00
total current assets	0	2089000	-100.00
total non current assets	0	375066000	-100.00
total current liabilities	29674000	58000	51062.07
total non current liabilities	234000	25996000	-99.10
common stock	37506000	37506000	0.00
retained earnings	0	369072824	-100.00
total debt	29674000	25996000	14.15

Overall Score of Quarterly Balance Sheet

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 384 million in 2024Q2 from 380 million in 2023Q4 representing a change of 1.11%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 355 million in 2024Q2 from 354 million in 2023Q4 representing a change of 0.15%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 9 million in 2024Q2 from 2 million in 2023Q4 representing a change of 308.71%. This indicates an increase in available liquid assets.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 30 million in 2024Q2 from 26 million in 2023Q4 representing a change of 14.06%. This indicates an increase in overall liabilities.

  Total Current Assets: Total Current Assets decreased to 0 million in 2024Q2 from 2 million in 2023Q4 representing a change of -100.0%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 30 million in 2024Q2 from 0 million in 2023Q4 representing a change of 51062.07%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 0 million in 2024Q2 from 369 million in 2023Q4 representing a change of -100.0%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 30 million in 2024Q2 from 26 million in 2023Q4 representing a change of 14.15%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-11228000	4975000	-325.69
operating cash flow	2727000	3414000	-20.12
free cash flow	2727000	3372228	-19.13
capital expenditure	0	-41771.6	100.00
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	41771	-100.00
investments in property plant and equipment	0	-41771.6	100.00
net cash used for investing activites	-10337000	49333000	-120.95
debt repayment	17704000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-20884000	-31688000	34.09
net cash used provided by financing activities	-3180000	-48861000	93.49
cash at end of period	2089000	13317000	-84.31
accounts receivables	-2000.0	25000	-108.00
cash at beginning of period	13317000	8342000	59.64

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	4678000	24000	19391.67
free cash flow	4678000	5524.42	84578.59
capital expenditure	0	-18475.58	100.00
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	-18475.58	100.00
net cash used for investing activites	8433000	-8459000	199.69
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-10622000	-10442000	-1.72
net cash used provided by financing activities	-6321000	-1617000	-290.91
net change in cash	6449000	-10008000	164.44
cash at end of period	8538000	2089000	308.71
cash at beginning of period	2089000	12097000	-82.73

Overall Score of Quarterly Cashflow Statement

None

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.1	-0.48	121.26
net income per share	0.1	-0.48	120.04
operating cash flow per share	0.01	0.01	-20.12
free cash flow per share	0.01	0.01	-19.13
cash per share	0.01	0.04	-84.31
book value per share	0.98	0.97	1.83
tangible book value per share	0.98	0.97	1.83
shareholders equity per share	0.98	0.97	1.83
interest debt per share	0.07	0.03	192.48
market cap	372012613.79	372535597.58	-0.14
enterprise value	395919613.79	368090597.58	7.56
pe ratio	10.66	-2.14	598.18
price to sales ratio	10.17	-2.16	569.73
pocfratio	136.42	109.12	25.02
pfcf ratio	136.42	110.47	23.49
pb ratio	1.05	1.07	-1.94
ptb ratio	1.05	1.07	-1.94
ev to sales	10.82	-2.14	605.96
enterprise value over ebitda	10.91	-2.13	612.45
ev to operating cash flow	145.19	107.82	34.66
ev to free cash flow	145.19	109.15	33.01
earnings yield	0.09	-0.47	120.07
free cash flow yield	0.01	0.01	-19.02
debt to equity	0.07	0.03	187.74
debt to assets	0.07	0.02	175.34
net debt to ebitda	0.66	0.03	2462.45
current ratio	0	2366.29	-100.00
interest coverage	51.48	-672.57	107.65
income quality	0.08	-0.02	488.84
dividend yield	0.06	0.09	-34.00
payout ratio	0.6	-0.18	428.79
sales general and administrative to revenue	0.02	-0.01	490.97
research and ddevelopement to revenue	0	-0.0	100.00
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	0.01	-100.00
capex to revenue	0	-0.0	100.00
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	1.46	3.24	-54.82
roic	0.09	-0.49	119.41
return on tangible assets	0.09	-0.49	118.84
graham net net	-0.07	0.01	-665.79
working capital	2089000	16557000	-87.38
tangible asset value	353996000	347627000	1.83
net current asset value	-24133000	6910000	-449.25
invested capital	2089000	16557000	-87.38
average receivables	1623500	1623500	0.00
average payables	32500	7500	333.33
average inventory	-1832869.5	-3424988	46.49
days sales outstanding	0	-6.89	100.00
days payables outstanding	7.4	0.8	827.91
days of inventory on hand	0	-417.6	100.00
receivables turnover	0	-53.01	100.00
payables turnover	49.33	457.71	-89.22
inventory turnover	0	-0.87	100.00
roe	0.1	-0.5	119.68
capex per share	0	0.0	-100.00

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 10.66 on 2023-12-31 from -2.14 on 2022-12-31, representing a change of 598.18%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio decreased to 0.00 on 2023-12-31 from 2366.29 on 2022-12-31, representing a change of -100.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.07 on 2023-12-31 from 0.03 on 2022-12-31, representing a change of 187.74%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
EAT.L
calendar year	2024	2023	NaN
revenue per share	0.06	0.02	168.50
net income per share	0.05	0.02	248.95
operating cash flow per share	0.01	0.0	19391.67
free cash flow per share	0.01	0.0	84578.59
cash per share	0.02	0.01	308.71
book value per share	0.98	0.98	0.15
tangible book value per share	0.98	0.98	0.15
shareholders equity per share	0.98	0.98	0.15
interest debt per share	0.08	0.07	14.15
market cap	367878490.33	372010832.61	-1.11
enterprise value	389014490.33	395917832.61	-1.74
pe ratio	4.78	16.86	-71.66
price to sales ratio	16.64	45.19	-63.17
pocfratio	78.64	15500.45	-99.49
pfcf ratio	78.64	67339.36	-99.88
pb ratio	1.04	1.05	-1.26
ptb ratio	1.04	1.05	-1.26
ev to sales	17.6	48.09	-63.41
enterprise value over ebitda	19.24	62.15	-69.05
ev to operating cash flow	83.16	16496.58	-99.50
ev to free cash flow	83.16	71666.87	-99.88
earnings yield	0.05	0.01	252.87
free cash flow yield	0.01	0.0	85529.77
debt to equity	0.08	0.07	13.98
debt to assets	0.08	0.07	12.90
net debt to ebitda	1.05	3.75	-72.15
current ratio	0	36.02	-100.00
interest coverage	0	0	NaN
income quality	0.24	0.0	5485.83
dividend yield	0.03	0.03	2.87
payout ratio	0.55	1.89	-70.85
sales general and administrative to revenue	0	0.13	-100.00
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	0.77	-100.00
capex to revenue	0	0.0	-100.00
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	1.09	0.58	86.94
roic	0	0.02	-100.00
return on tangible assets	0.05	0.01	245.13
graham net net	-0.05	-0.08	29.98
working capital	-29674000	2031000	-1561.05
tangible asset value	354514000	353996000	0.15
net current asset value	-29908000	-24133000	-23.93
invested capital	-29674000	2031000	-1561.05
average receivables	None	0	NaN
average payables	None	29000	NaN
average inventory	None	-3283959.5	NaN
days sales outstanding	11.8	0	NaN
days payables outstanding	0	3.94	-100.00
days of inventory on hand	0	-445.79	100.00
receivables turnover	7.63	0	NaN
payables turnover	0	22.86	-100.00
inventory turnover	0	-0.2	100.00
roe	0.05	0.02	248.44
capex per share	0	0.0	-100.00

• Negative

  ROE: Return on Equity (ROE) increased to 0.05 on 2024-06-30 Q2 from 0.02 on 2023-12-31 Q4, representing a change of 248.44%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 4.78 on 2024-06-30 Q2 from 16.86 on 2023-12-31 Q4, representing a change of -71.66%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 0.00 on 2024-06-30 Q2 from 36.02 on 2023-12-31 Q4, representing a change of -100.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.08 on 2024-06-30 Q2 from 0.07 on 2023-12-31 Q4, representing a change of 13.98%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 2.01 which is lower than current price 83, indicates the company may be overvalued.